In my first reading speech I talked about the committee asking two questions: is this the right thing to do, and is this the right way to do it? Now, to the degree that we are seeking equity and removing barriers to people actually getting their fourth dose if they are eligible for it, we are achieving that goal, and people have talked in this reading about the evidence of benefit. I'm not convinced it's as strong as people would suggest. The Minister talked about the plethora of countries that are doing this—the second booster—and by my count there are only seven, which leaves over 190 countries that are not doing it. As recently as last month, the World Health Organization reviewed the evidence for a fourth COVID dose and said that the lack of data exists and it may show some short-term benefit for those over the age of 60, but a very tenuous benefit for anybody else. Pfizer themselves, in their four-paragraph submission to the committee, made a telling comment: "Recommending the use of an additional booster is a decision for the New Zealand Government". So they were ambivalent, at best, about it. 